Evaluation of Ornithine Decarboxylase and Ferric Reducing Capacity Levels as Potential Biomarkers for Polycystic Ovary Syndrome

• Published in: Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry Vol. 19; no. 2; pp. 145 - 154
• Main Authors: Noor, Jasim Mohamed, Al-Ani, Ali Waleed
• Format: Journal Article
• Language: English
• Published: Moscow Pleiades Publishing 01.06.2025; Springer Nature B.V
• Subjects: Biomarkers; Bioorganic Chemistry; Chemistry; Chemistry and Materials Science; Insulin resistance; Medicinal Chemistry; Metformin; Ornithine decarboxylase; Ovaries; Polycystic ovary syndrome; Statistical analysis; homeostatic model assessment for insulin resistance; ornithine decarboxylase; anti-mullerian hormone; ferric reducing capacity; polycystic ovary syndrome

Background: Polycystic ovary syndrome (PCOS) is a prevalent hormonal disorder affecting reproductive-age women, often linked to metabolic issues like insulin resistance. Objective: this study aimed to evaluate ornithine decarboxylase (ODC) and ferric reducing capacity (FRC) levels in women with PCOS...